A Guide for Pain Management in Developing Nations: The Diagnosis and Assessment of Pain in Cancer Patients
- Authors
-
-
Joseph V. Pergolizzi
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, USA 2Department of Anesthesiology, Georgetown University School of Medicine, Washington, D.C., USA 3Department of Pharmacology, Temple University School of Medicine, Philadelphia, PA, USA -
Gianpietro Zampogna
NEMA Research, Naples, Florida, USA -
Robert Taylor
NEMA Research, Naples, Florida, USA -
Marixa Guerrero
Medical Director of Instituto de Ortopedia Roosevelt, Bogota, Colombia -
Juan Quillermo Santacruz
Palliativist of Fundacion Santa fe, Bogota, Colombia -
Robert B. Raffa
Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA
-
- Keywords:
- Cancer pain, malignant pain, opioid analgesia, opioids, undertreatment of cancer pain, assessment of cancer pain.
- Abstract
-
The fundamental approach to cancer patients with pain is to identify the pain sites, and describe, quantify, and categorize the pain by type at each site. There are many validated tools to serve the clinician in these efforts, particularly for pain assessment. Multimechanistic pain syndromes are common in cancer patients. Cancer patients may experience nociceptive pain. They may also experience neuropathic pain due to chemotherapy-induced or cancer-related nerve damage. Analgesic choices must be guided by the pain mechanisms, nature, and severity of the pain, comorbid conditions, and patient characteristics. Long-acting opioid analgesics or fixed-clock dosing can eliminate end-of-dose analgesic gaps. The potential for opioid abuse is an important public health challenge but one that should not undermine the appropriate treatment of moderate to severe cancer pain. Abuse-deterrent opioid formulations can be useful. Care is needed for special populations of cancer patients dealing with pain, such as geriatric, pediatric, or obese patients. While morphine has long been the gold standard of oral opioid products, recent clinical trials suggest that oral hydrocodone and oral oxycodone may offer advantages over oral morphine. Patient adherence is crucial for adequate analgesia and patient education can promote adherence and manage expectations.
- Downloads
-
Download data is not yet available.
- Downloads
- Published
- 14-01-2016
- Issue
- Vol. 5 No. 1 (2016)
- Section
- Articles
How to Cite
Similar Articles
- Satoshi Hibi, Yuko Shirokawa, Kengo Nanya, Tatsuya Kawamura, Yuko Kato, Shu Yuasa, Satoshi Kayukawa, Kenji Ina, Evaluation of HBV-DNA Monitoring after Completion of Chemotherapy using a PDCA Cycle following Introduction of a Support System Provided by a Multidisciplinary Team of Quality Management in Cancer Medicine , Journal of Cancer Research Updates: Vol. 14 (2025)
- Muqaddam Shohzodaeva, Uldoshev Ravshan Zohidovich, Rachel Kansiime, Joyeeta Talukdar, From Hidden Burden to Visible Care: Integrating Psycho-Oncology into Breast Cancer Control in Tajikistan through Indian and African Models , Journal of Cancer Research Updates: Vol. 15 No. 1 (2026)
- F. Gloria-Bottini, M. Nicotra, C. Spina, P.L. Benedetti-Panici, P. Saccucci, A. Neri, A. Magrini, E. Bottini, P53 Codon 72 and Endometrium Cancer , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- César Paz-y-Miño, Carolina Salazar, Tania Zurita, Andrés López-Cortés, Ramiro Hidalgo, Felipe Rosales, Alexandra Montalvo, Paola E. Leone, Positive Association between the Polymorphic Variant CCND1 A870G and Colorectal Cancer in Ecuadorian Mestizo Population , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Dimple Sethi Chopra , Challenges in Development of Nanomedicine for Treatment of Cancer , Journal of Cancer Research Updates: Vol. 8 No. 1 (2019)
- Halkia Evgenia, Spiliotis John, Sugarbaker Paul, Second Look Proactive Surgery for Colon Cancer with Peritoneal Carcinomatosis , Journal of Cancer Research Updates: Vol. 1 No. 2 (2012)
- Kenji Ina, Ryuichi Furuta, Megumi Kabeya, Takashi Yoshida, Takae Kataoka, Satoshi Kayukawa, S-1 Plus Leucovorin and Oxaliplatin in Combination with Lentinan as First-line Therapy in Patients with Metastatic Gastric Cancer , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Janet Wangari-Talbot, Elizabeth Hopper-Borge, Drug Resistance Mechanisms in Non-Small Cell Lung Carcinoma , Journal of Cancer Research Updates: Vol. 2 No. 4 (2013)
- Alfred Böcking, David Friedrich, Branko Palcic, Dietrich Meyer-Ebrech, Jin Chen, Diagnostic and Prognostic DNA-Karyometry for Cancer Diagnostics , Journal of Cancer Research Updates: Vol. 9 No. 1 (2020)
- Fei Zhou, Lothar Esser, Di Xia, Recent Advances in Understanding the Structure and Function Relationship of Multidrug Resistance-Linked ABC Transporter P-glycoprotein , Journal of Cancer Research Updates: Vol. 5 No. 3 (2016)
You may also start an advanced similarity search for this article.
Most read articles by the same author(s)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)